Essential drugs in the new international economic environment.
Recent global developments in the regulation of trade and intellectual property rights threaten to hinder the access of populations in developing countries to essential drugs. The authors argue for state intervention in the health and pharmaceutical markets in order to guarantee equitable access to these products.
Velásquez
G
G
Action Programme on Essential Drugs, World Health Organization, Geneva, Switzerland.
Boulet
P
P
D001709:Biotechnology / Q000639:trends; D003132:Commerce / Q000331:legislation & jurisprudence; D003906:Developing Countries; D018954:Drugs, Essential / Q000191:economics*; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D007391:International Cooperation; D010330:Patents as Topic / Q000331:legislation & jurisprudence
D018954:Drugs, Essential